BOSTON MASSACHUSSETTS and MORRISTOWN, NEW JERSEY–(BIOAEGIS THERAPEUTICS – July 26, 2013) BioAegis Therapeutics announced today that a patent has been granted in Japan that that covers the diagnostic claims of the therapeutic and diagnostic application. Further Japanese applications for therapeutic claims in inflammation are pending.
July 26, 2013: Plasma Gelsolin Inflammation Patent Granted in Japan, Further Expanding Coverage in Asia
- July 26, 2013